Gene Patenting
A recent US Supreme Court ruling found that companies cannot patent things found in nature. Peter Day asks what this means for the biotech business.
Ever since the mapping of the human genome was completed 10 years ago medical companies have been rushing to patent genes that define all of us for their own exclusive use. Now the US Supreme Court has ruled against patenting things found in nature. Peter Day asks what this means for the biotech business.and for the future of healthcare.
Last on
Contributors to this programme
Professor Sir John Burn
Professor of Clinical Genetics, Institute of Genetic Medicine Newcastle University
Ìý
Ìý
David Koepsell
Author, Who Owns You?
ÌýJulian Hitchcock
Life Science Lawyer, Lawford Davies Denoon
ÌýDr Michael Hopkins
Senior Lecturer, University of Sussex
ÌýDr Berwyn Clarke
Entrepreneur
ÌýDr Hani Gabra
Professor of Medical Oncology, Imperial College London
ÌýDr Helen Wallace
Director Genewatch UK
ÌýDr Stuart Hogarth
Research Fellow, Kings College London
Ìý
Ìý
Ìý
Broadcasts
- Thu 8 Aug 2013 20:30Â鶹Éç Radio 4
- Sun 11 Aug 2013 21:30Â鶹Éç Radio 4
Download this programme
Subscribe to this programme or download individual episodes.